English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend

February 13, 2025

13 Feb 2025

Acarix AB (publ) Publishes Year-End Report 2024 – Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts

Malmö — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial res...

Continue reading

Interim, IR, Listing Regulation, News, Q3, Regulatory, Report, Swedish

November 18, 2024

07 Nov 2024

Acarix AB (publ) publicerar tredje kvartalet 2024

Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, redovisade idag sina finansiella resultat för det tredje ...

Continue reading

English, Interim, IR, Listing Regulation, News, Q3, Regulatory, Report

November 18, 2024

07 Nov 2024

Acarix Publishes Third Quarter 2024 Report

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 202...

Continue reading

acarix

Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares

November 18, 2024

01 Oct 2024

Acarix resolves on a directed issue to the guarantors of the warrant series 3

Acarix AB ("Acarix" or the "Company") today announces that the Board of Directors has resolved on a directed issue to the guarantors of...

Continue reading

acarix

Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory

November 18, 2024

26 Sep 2024

Acarix announces outcome of warrant exercise of series 3

Acarix AB ("Acarix" or the "Company") today announces the outcome of the exercise of warrants of series 3 issued in connection with the...

Continue reading

acarix

Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory

November 18, 2024

11 Sep 2024

Acarix informs of exercise price for the warrants of series TO 3

Acarix AB ("Acarix" or the "Company"), a leader in rapid AI and acoustics-based cardiac diagnostics, announces that the exercise price ...

Continue reading

acarix

English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report

November 18, 2024

22 Aug 2024

Acarix AB (publ) publishes Interim Report, April – June 2024

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...

Continue reading

acarix

Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish

November 18, 2024

14 May 2024

Kommuniké från årsstämma i Acarix AB

Årsstämman 2024 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 14 maj 2024 varvid aktieägarna fattade f&oum...

Continue reading

acarix

Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM

November 18, 2024

14 May 2024

Announcement from the annual general meeting in Acarix AB

The annual general meeting 2024 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 14 May 2024 and the following re...

Continue reading

acarix

English, Interim, IR, Listing Regulation, News, Q1, Regulatory, Report

November 18, 2024

14 May 2024

Acarix AB (publ) publishes Interim Report, January – March 2024

Setting the stage for a strong 2024 and beyondOne of the most notable achievements this quarter has been the successful implementation ...

Continue reading

acarix

Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory

November 18, 2024

03 May 2024

Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)

The Nomination Committee of Acarix consists of Jan Poulsen (Chairman) representing Life Science Invest Fund 1 among others, Anton Rehns...

Continue reading

acarix

Annual, English, IR, Listing Regulation, News, Regulatory, Report

November 18, 2024

23 Apr 2024

Acarix AB’s Annual Report 2023

Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2023 is available as a pdf ...

Continue reading